Damage, inflammation, and injury following neonatal HI. J Cereb Blood Flow Metab. 2011; 31:178?89. [PubMed: 20571523] 93. Welz PS, Wullaert A, Vlantis K, Kondylis V, Fernandez-Majada V, Ermolaeva M, Kirsch P, Sterner-Kock A, van Loo G, Pasparakis M. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature. 2011; 477:330?34. [PubMed: 21804564] 94. Kang TB, Yang SH, Toth B, Kovalenko A, Wallach D. Caspase-8 Blocks Kinase RIPK3-Mediated Activation of your NLRP3 Inflammasome. Immunity. 2012; 38:27?0. 95. Scharner D, Rossig L, Carmona G, Chavakis E, Urbich C, Fischer A, Kang TB, Wallach D, Chiang YJ, Deribe YL, Dikic I, Zeiher AM, Dimmeler S. Caspase-8 is involved in neovascularizationpromoting progenitor cell functions. Arterioscler Thromb Vasc Biol. 2009; 29:571?78. [PubMed: 19122169]NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author ManuscriptJ Immunol. Author manuscript; available in PMC 2015 March 01.Mocarski et al.Page96. Liu K, Victora GD, Schwickert TA, Guermonprez P, Meredith MM, Yao K, Chu FF, Randolph GJ, Rudensky AY, Nussenzweig M. In vivo evaluation of dendritic cell improvement and homeostasis. Science. 2009; 324:392?97. [PubMed: 19286519] 97. Kang TB, Oh GS, Scandella E, Bolinger B, Ludewig B, Kovalenko A, Wallach D. Mutation of a self-processing web site in caspase-8 compromises its apoptotic but not its nonapoptotic functions in bacterial artificial chromosome-transgenic mice. J Immunol. 2008; 181:2522?532. [PubMed: 18684943] 98. Ben Moshe T, Kang TB, Kovalenko A, Barash H, Abramovitch R, Galun E, Wallach D. Cellautonomous and non-cell-autonomous functions of caspase-8. Cytokine Growth Factor Rev. 2008; 19:209?17. [PubMed: 18555200] 99. Kang TB, Ben-Moshe T, Varfolomeev EE, Pewzner-Jung Y, Yogev N, Jurewicz A, Waisman A, Brenner O, Haffner R, Gustafsson E, Ramakrishnan P, Lapidot T, Wallach D. Caspase-8 serves each apoptotic and nonapoptotic roles. J Immunol. 2004; 173:2976?984. [PubMed: 15322156] 100. Moulin M, Anderton H, Voss AK, Thomas T, Wong WW, Bankovacki A, Feltham R, Chau D, Cook WD, Silke J, Vaux DL. IAPs limit activation of RIP kinases by TNF receptor 1 through development.3-Fluoro-2-methyl-6-nitropyridine structure EMBO J. 2012; 31:1679?691. [PubMed: 22327219] 101. Vince JE, Wong WW, Gentle I, Lawlor KE, Allam R, O’Reilly L, Mason K, Gross O, Ma S, Guarda G, Anderton H, Castillo R, Hacker G, Silke J, Tschopp J. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity. 2012; 36:215?27. [PubMed: 22365665] 102. Silke J, Hartland EL. Masters, marionettes and modulators: intersection of pathogen virulence variables and mammalian death receptor signaling. Curr Opin Immunol. 2013; 25:436?40. [PubMed: 23800628] 103.2-Bromo-4-chloro-3-fluorobenzaldehyde web Andrews DM, Estcourt MJ, Andoniou CE, Wikstrom ME, Khong A, Voigt V, Fleming P, Tabarias H, Hill GR, van der Most RG, Scalzo AA, Smyth MJ, Degli-Esposti MA.PMID:32695810 Innate immunity defines the capacity of antiviral T cells to limit persistent infection. J Exp Med. 2010; 207:1333?343. [PubMed: 20513749] 104. Sumaria N, van Dommelen SL, Andoniou CE, Smyth MJ, Scalzo AA, Degli-Esposti MA. The roles of interferon-gamma and perforin in antiviral immunity in mice that differ in genetically determined NK-cell-mediated antiviral activity. Immunol Cell Biol. 2009; 87:559?66. [PubMed: 19564888] 105. Lin ML, Zhan Y, Villadangos JA, Lew AM. The cell biology of cross-presentation plus the part of dendritic cell subsets. Immunol Cell Biol. 2008; 86:353?62. [PubMed: 18268517] 106. Albert ML. Death-d.